The US Food and Drug Administration (FDA) has approved Sanofi and Regeneron’s Dupixent (dupilumab) as a treatment option for adults with bullous pemphigoid (BP), a condition that predominantly ...

We recently published 10 Most Undervalued Pharma Stocks To Buy Now. Sanofi stands ninth on our list and is currently making ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the 11 Best 52-Week Low Stocks to Buy Right Now. On June 20, ...

Treatment and Prognosis Patients with BP will often go into remission if young, usually less than 65 years old, and in good health, but erupting blisters can continue for 10 or more years. About ...

They cautioned that cases of bullous pemphigoid have recently been reported in patients after beginning treatment with dipeptidyl peptidase 4 inhibitors such as sitagliptin (Januvia) and ...

EM does not have the chronic nature that BP has; lesions in EM minor clear in 2–3 weeks, and EM major lesions heal in 3–6 weeks with symptomatic treatment (Pruksachatkunakorn, 2007).

Pharmaceutical manufacturing in the U.S. has declined sharply over recent decades, with most active ingredient production shifting overseas due to lower labor costs. In 2023, the U.S.

Shares of Regeneron Pharmaceuticals, Inc. REGN have lost 22.6% year to date against the industry’s growth of 0.6%. The stock ...

As frustrating as that is, there are things you can do to make sure that your doctor turns your symptoms into an accurate diagnosis. Here's what to know. The first step to getting an accurate ...

Covid is making a comeback in Ireland with 180 new cases reported recently, driven in part by the fast-spreading Nimbus variant that brings unusual symptoms.